Enough About EpiPen? Hardly
After this week’s blistering questioning of Mylan CEO Heather Bresch by a House committee, USA Today ran a piece headlined “5 things we learned from the EpiPen price hike hearing.” No. 4: When drug companies are called out for what critics call exorbitant pricing, they go into a mode that Rep. Elijah Cummings of Tennessee compares with Muhammad Ali’s “rope-a-dope” strategy. They take their punches and “keep raising their prices,” Cummings said. And, as proof that the EpiPen controversy has penetrated the public consciousness, here’s a clip of Jimmy Kimmel from last week’s Emmy Awards broadcast.
Zuckerberg, Chan Want to End Disease
The famed chief executive of Facebook, Mark Zuckerberg, and his wife, pediatrician Priscilla Chan, have done pretty well for themselves, and the couple recently pledged more than $3 billion to “cure, prevent or manage all diseases within our children’s lifetime,” Reuters reports. The money will go toward building a bioscience center, dubbed Biohub, creating a chip to diagnose diseases, and developing ways to constantly monitor the bloodstream and map cell types in the body. Let's see how many share the news on Facebook.
The Global Threat of Superbugs
For only the fourth time in the United Nations' history, the general assembly held a meeting on a health care issue. The topic this time was drug-resistant infections, which, as reported in The Guardian, Secretary General Ban Ki-moon called a “fundamental threat” to global health and safety. So-called superbugs kill more than 700,000 people each year. All 193 UN member nations signed a declaration committed to encouraging innovation in antibiotic development, increasing public awareness, and developing surveillance and regulatory systems on the use and sales of antimicrobial medicine for humans and animals. For more on the issue, go to H&HN’s superbug section.
Inspiring Doc Receives Long Overdue Apology
Surrounded by hundreds of friends, family and supporters, Alvin Blount received an apology from Cone Health for the hospital’s past practice of excluding African-American physicians like Blount, as well as black patients, North Carolina Health News reports. Blount, 94, along with many of his peers, successfully won a landmark case during the 1960s that paved the way for hospital integration across the U.S. “This decision ended ‘separate but equal’ forever!” he said in the report.